Systematic review of recent advances in pharmacokinetics of four classical Chinese medicines used for the treatment of cerebrovascular disease

Fitoterapia

Volumn 88, Issue , 2013, Pages 50-75

  Zeng, Mingfei ^a   Pan, Linmei ^b   Qi, Shunmei ^c   Cao, Yuntai ^c   Zhu, Huaxu ^b   Guo, Liwei ^b   Zhou, Jing ^b  

^a Thermo Fisher Scientific   (United States)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c WUXI APPTEC   (China)

Author keywords

ADME (absorption, distribution, metabolism and excretion); Bioavailability; Cerebrovascular disease; Chinese medicine; Drug interaction; Pharmacokinetics

Indexed keywords

BORNEOL; CARBOMER; GARDENIA EXTRACT; GENIPOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RG 1; LIGUSTICUM CHUANXIONG EXTRACT; PANAX NOTOGINSENG EXTRACT; SALVIA MILTIORRHIZA EXTRACT; TETRAMETHYLPYRAZINE;

AREA UNDER THE CURVE; CELL TRANSPORT; CEREBROVASCULAR DISEASE; CHINESE MEDICINE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG STRUCTURE; GARDENIA; HUMAN; LIGUSTICUM CHUANXIONG; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PANAX NOTOGINSENG; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SALVIA MILTIORRHIZA; STOMACH JUICE; SYSTEMATIC REVIEW; TIME TO MAXIMUM PLASMA CONCENTRATION;

GARDENIA; LIGUSTICUM CHUANXIONG; PANAX NOTOGINSENG; SALVIA MILTIORRHIZA;

EID: 84878904952     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.04.006     Document Type: Review

References (174)

1. S. Meairs, N. Wahlgren, U. Dirnagl, O. Lindvall, P. Rothwell, and J.C. Baron Stroke research priorities for the next decade - a representative view of the European scientific community Cerebrovasc Dis 22 2006 75 82
2. Z. Lin, J. Gu, J. Xiu, T. Mi, J. Dong, and J.K. Tiwari Traditional Chinese medicine for senile dementia Evid Based Complement Altern Med 2012 1 13
3. Y.S. Ho, K.F. So, and R.C. Chang Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia Chin Med 6 2011 15
4. X. Shang, X. He, X. He, M. Li, R. Zhang, and P. Fan The genus Scutellaria an ethnopharmacological and phytochemical review J Ethnopharmacol 128 2010 279 313
5. P. Xiao, and C. Liu Pharmacology, pharmacokinetics and toxicology of Chinese traditional medicine for stroke therapy Asian J Drug Metab Pharmacokinet 5 2005 83 124
6. M. Ye, S. Fu, R. Pi, and F. He Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research J Pharm Pharmacol 61 2009 831 837
7. P.J. Eddershaw, A.P. Beresford, and M.K. Bayliss ADME/PK as part of a rational approach to drug discovery Drug Discov Today 5 2000 409 414 (Pubitemid 30645737)
8. H.E. Selick, A.P. Beresford, and M.H. Tarbit The emerging importance of predictive ADME simulation in drug discovery Drug Discov Today 7 2002 109 116 (Pubitemid 34088134)
9. M. Zheng, L. Qu, and Y. Lou Effects of icariin combined with Panax notoginseng saponins on ischemia reperfusion-induced cognitive impairments related with oxidative stress and CA1 of hippocampal neurons in rat Phytother Res 22 2008 597 604 (Pubitemid 351716546)
10. C.M. Chuang, C.L. Hsieh, and H.Y. Lin Panax notoginseng Burk attenuates impairment of learning and memory functions and increases ED1, BDNF and beta-secretase immunoreactive cells in chronic stage ischemia-reperfusion injured rats Am J Chin Med 36 2008 685 693
11. H. Li, C.Q. Deng, B.Y. Chen, S.P. Zhang, Y. Liang, and X.G. Luo Total saponins of Panax notoginseng modulate the expression of caspases and attenuate apoptosis in rats following focal cerebral ischemia-reperfusion J Ethnopharmacol 121 2009 412 418
12. H.Y. Son, H.S. Han, H.W. Jung, and Y.K. Park Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia J Pharmacol Sci 109 2009 368 379
13. K. Yu, F. Chen, and C. Li Absorption, disposition, and pharmacokinetics of saponins from Chinese medicinal herbs: what do we know and what do we need to know more? Curr Drug Metab 13 2012 577 598
14. H. Liu, J. Yang, F. Du, X. Gao, X. Ma, and Y. Huang Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats Drug Metab Dispos 37 2009 2290 2298
15. W. Chen, Y.J. Dang, and C.Y. Zhu Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study Chin Med 5 2010 12
16. L. Li, Y. Sheng, J. Zhang, C. Wang, and D. Guo HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies Biomed Chromatogr 18 2004 849 856 (Pubitemid 40089858)
17. X. Li, G. Wang, J. Sun, H. Hao, Y. Xiong, and B. Yan Pharmacokinetic and absolute bioavailability study of total panax notoginsen Biol Pharm Bull 30 2007 847 851
18. L. Lin, J.X. Liu, Y. Zhang, and C.L. Duan Pharmacokinetic studies of ginsenoside Rg1, Re, Rb1 and Rd in rats by LC-MS/MS method Chin Pharm 44 2009 373 377
19. M. Song, S.Y. Zhang, X.Y. Xu, and T.J. Hang Simultaneous determination of three Panax notoginseng saponins at sub-nanograms by LC-MS/MS in dog plasma for pharmacokinetics of compound Danshen tablets J Chromatogr B Analyt Technol Biomed Life Sci 878 2010 3331 3337
20. Q.F. Xu, X.L. Fang, and D.F. Chen Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats J Ethnopharmacol 84 2003 187 192 (Pubitemid 36324258)
21. M. Han, and X.L. Fang Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models Yao Xue Xue Bao 27 2006 499 505
22. M. Han, L.M. Han, Q.S. Wang, Z.H. Bai, and X.L. Fang Mechanism of oral absorption of Panax notoginseng saponins Yao Xue Xue Bao 41 2006 498 505 (Pubitemid 44174275)
23. M. Han, X. Sha, Y. Wu, and X. Fang Oral absorption of ginsenoside Rb1 using in vitro and in vivo models Planta Med 72 2006 398 404
24. L. Feng, X.H. Jiang, J. Zhou, and J.Y. Yang Studies on absorption kinetics of sanchinoside R1 and ginsenoside Rg1 in rat intestine Chin Pharm J 41 2006 1097 1102 (Pubitemid 44386939)
25. F. Liang, and J.X. Hua Absorption profiles of sanchinoside R1 and ginsenoside Rg1 in the rat intestine Eur J Drug Metab Pharmacokinet 30 2005 261 268 (Pubitemid 43099305)
26. J. Xiong, J. Guo, L. Huang, B. Meng, and Q. Ping The use of lipid-based formulations to increase the oral bioavailability of Panax notoginseng saponins following a single oral gavage to rats Drug Dev Ind Pharm 34 2008 65 72 (Pubitemid 351156965)
27. J. Xiong, J. Guo, L. Huang, B. Meng, and Q. Ping Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginseng Int J Pharm 360 2008 191 196
28. W. Zhou, R.B. Shi, J.N. Sun, and Y.Y. Wang Pharmacokinetics of effective fractions of Qingnaoxuanqiao Formula in different rat models J Beijing Univ Tradit Chin Med 31 2008 265 268
29. C. Wakabayashi, H. Hasegawa, J. Murata, and I. Saiki In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration Oncol Res 9 1997 411 417 (Pubitemid 127825994)
30. L. Li, Y.X. Sheng, J.L. Zhang, S.S. Wang, and D.A. Guo High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues Biomed Chromatogr 20 2006 327 335
31. L. Feng, L. Wang, C. Hu, and X. Jiang Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats Arch Pharm Res 33 2010 1975 1984
32. T. Lu, Y. Jiang, and Z. Zhou Intranasal ginsenoside Rb1 targets the brain and ameliorates cerebral ischemia/reperfusion injury in rats Biol Pharm Bull 34 2011 1319 1324
33. G. Chen, L. Mu, X. Zhang, S. Hou, and H. Nan In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration Zhongguo Zhong yao za zhi 36 2011 1815 1820
34. S.X. Wang, W.F. Miao, M.F. Fang, Y.F. Nan, X.Y. Meng, and X.H. Zheng Effect of borneol on the tissue distribution of notoginseng R1, ginsenoside Rg1 and Re in rabbits J Fourth Mil Med Univ 30 2009 2750 2752
35. J.Q. Ruan, W.I. Leong, R. Yan, and Y.T. Wang Characterization of metabolism and in vitro permeability study of notoginsenoside R1 from Radix Notoginseng J Agric Food Chem 58 2010 5770 5776
36. X.D. Wen, J. Yang, R.H. Ma, W. Gao, L.W. Qi, and P. Li Analysis of Panax notoginseng metabolites in rat bile by liquid chromatography-quadrupole time-of-flight mass spectrometry with microdialysis sampling J Chromatogr B Analyt Technol Biomed Life Sci 895-6 2012 162 168
37. R. Liu, M. Qin, P. Hang, Y. Liu, Z. Zhang, and G. Liu Effects of Panax notoginseng saponins on the activities of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 in rats in vivo Phytother Res 8 2012 1113 1138
38. M. Han, S. Fu, and X.L. Fang Comparison between the characteristics of absorption and pharmacokinetic behavior of ginsenoside Rg1 and ginsenoside Rb1 of Panax notoginseng saponins Yao Xue Xue Bao 42 2007 849 853
39. T. Odani, H. Tanizawa, and Y. Takino Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. Theabsorption, distribution and excretion of ginsenoside Rg1 in the rat Chem Pharm Bull (Tokyo) 31 1983 292 298 (Pubitemid 13122244)
40. T. Odani, H. Tanizawa, and Y. Takino Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. IV. Decomposition of ginsenoside-Rg1 and -Rb1 in the digestive tract of rats Chem Pharm Bull (Tokyo) 31 1983 3691 3697 (Pubitemid 14204435)
41. L. Li, J.L. Zhang, Y.X. Sheng, G. Ye, H.Z. Guo, and D.A. Guo Liquid chromatographic method for determination of four active saponins from Panax notoginseng in rat urine using solid-phase extraction J Chromatogr B Analyt Technol Biomed Life Sci 808 2004 177 183 (Pubitemid 38952912)
42. X.Y. Ji, and Y.Z. Zhu Salvia miltiorrhiza and ischemic diseases Yao Xue Xue Bao 21 2000 1089 1094
43. C.J. Lo, J.G. Lin, J.S. Kuo, S.Y. Chiang, S.C. Chen, and E.T. Liao Effect of Salvia miltiorrhiza bunge on cerebral infarct in ischemia-reperfusion injured rats Am J Chin Med 31 2003 191 200
44. L. Zhou, Z. Zhong, and S.S.C. Moses Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J Clin Pharmacol 45 2005 1345 1359 (Pubitemid 41643896)
45. J. Ho, and C.Y. Hong Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection J Biomed Sci 18 2011 30
46. M. Jiang, X.Y. Wang, W.Y. Zhou, J. Li, J. Wang, and L.P. Guo Cerebral protection of salvianolic acid A by the inhibition of granulocyte adherence Am J Chin Med 39 2011 111 120
47. B.Y. Lam, A.C. Lo, X. Sun, H.W. Luo, S.K. Chung, and N.J. Sucher Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice Phytomedicine 10 2003 286 291 (Pubitemid 36597164)
48. X.R. Zhang, and W.S. Pan Studies on the absorptive kinetics of salvianoic acid A in rats' small intestines in vivo J Shenyang Pharm Univ 19 2002 13 17
49. Y.F. Zhang, Y.J. Li, Q. Yang, X.G.1 Weng, Y. Dong, and X.X. Zhu Intestine absorption study on danshensu and salvianolic acid B with rat in situ single pass perfusion model Chinese Chin J Exp Tradit Med Form 16 2010 96 100
50. L. Zhou, M.S. Chow, and Z. Zuo Effect of sodium caprate on the oral absorptions of danshensu and salvianolic acid B Int J Pharm 379 2009 109 118
51. H.H. Kim, J. Kim, H.Y. Ji, Y.C. Kim, D.H. Sohn, and B.M. Lee Pharmacokinetics of lithospermic acid B isolated from Salvia miltiorrhiza in rats J Toxicol Environ Health A 68 2005 2239 2247 (Pubitemid 41755680)
52. T. Lu, J. Yang, X. Gao, P. Chen, F. Du, and Y. Sun Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular Chinese medicine Drug Metab Dispos 36 2008 1578 1586
53. Y. Zhang, T. Akao, N. Nakamura, C.L. Duan, M. Hattori, and X.W. Yang Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza in rat Planta Med 70 2004 138 142 (Pubitemid 38299775)
54. D.Y. Gao, L.M. Han, and L.H. Zhang Bioavailability of salvianolic acid B and effect on blood viscosities after oral administration of salvianolic acids in beagle dogs Arch Pharm Res 32 2009 773 779
55. H. Yan, Q. Wu, S. Du, Y. Yang, L. Zhou, and X. Li Absorption mechanism of tanshinoneII-A, cryptotanshinone, tanshinone I and tanshinones extract in rat small intestine in vivo Zhongguo Zhong yao za zhi 35 2010 2917 2922
56. H. Hao, G. Wang, N. Cui, J. Li, L. Xie, and Z. Ding Pharmacokinetics, absorption and tissue distribution of tanshinone IIA solid dispersion Planta Med 72 2006 1311 1317 (Pubitemid 44862033)
57. M. Song, T.J. Hang, and Z.X. Zhang Determination of cryptotanshinone and its metabolite in rat plasma by liquid chromatography-tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 827 2005 205 209 (Pubitemid 41570117)
58. J. Zhang, M. Huang, S. Guan, H.C. Bi, Y. Pan, and W. Duan A mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhiza J Pharmacol Exp Ther 317 2006 1285 1294 (Pubitemid 43764135)
59. M. Song, T.J. Hang, and Z.X. Zhang Comparative study on pharmacokinetics of cryptotanshinone and tanshinones extract of Salvia miltiorrhiza Bge. in rats Chin Pharm J 43 2008 51 54
60. M. Song, T.J. Hang, Z. Zhang, and H.Y. Chen Effects of the coexisting diterpenoid tanshinones on the pharmacokinetics of cryptotanshinone and tanshinone IIA in rat Eur J Pharm Sci 32 2007 247 253 (Pubitemid 350051887)
61. B.B. Chang, L. Zhang, W.W. Cao, Y. Cao, W.L. Yang, and Y. Wang Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats Yao Xue Xue Bao 31 2010 638 646
62. L. Hu, Q. Xing, J. Meng, and C. Shang Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles AAPS PharmSciTech 11 2010 582 587
63. Y.J. Zhang, L. Wu, Q.L. Zhang, J. Li, F.X. Yin, and Y. Yuan Pharmacokinetics of phenolic compounds of Danshen extract in rat blood and brain by microdialysis sampling J Ethnopharmacol 136 2011 129 136
64. P.F. Yu, W.Y. Wang, G. Eerdun, T. Wang, L.M. Zhang, and C. Li The role of P-glycoprotein in transport of Danshensu across the blood-brain barrier Evid Based Complement Altern Med 2011 1 5
65. B.Q. Wang, Z.G. Pang, and Y.H. Xu A study on distribution of tanshinone A in a rabbit's viscera J Shenyang Pharm Univ 16 1999 206 208
66. S.S. Hu, J. Liu, S.J. Liu, M.F. Fang, S.X. Wang, and W.J. Sun Distribution of Danshensu in rabbit tissues by HPLC-FLD J Fourth Mil Med Univ 29 2008 670 672
67. R. Yang, Y.M. Wei, X. Li, S.S. Hu, M.F. Huang, and X.H. Zheng Tissue distribution of Danshensu in Huoxue Huayu formulae in rabbits by LC-MS/MS J Chin Pharm Univ 39 2008 155 158 (Pubitemid 351689583)
68. F.Q. Zhao, and A.L. Wang The distribution of Danshensu in rabbit Chin Pharm J 29 1994 291 293
69. M. Xu, G. Fu, X. Qiao, W.Y. Wu, H. Guo, and A.H. Liu HPLC method for comparative study on tissue distribution in rat after oral administration of salvianolic acid B and phenolic acids from Salvia miltiorrhiza Biomed Chromatogr 21 2007 1052 1063 (Pubitemid 47490315)
70. Y. Zhang, T. Akao, N. Nakamura, M. Hattori, X.W. Yang, and C.L. Duan Magnesium lithospermate B is excreted rapidly into rat bile mostly as methylated metabolites, which are potent antioxidants Drug Metab Dispos 32 2004 752 757 (Pubitemid 38821877)
71. H. Hao, G. Wang, P. Li, J. Li, and Z. Ding Simultaneous quantification of cryptotanshinone and its active metabolite tanshinone IIA in plasma by liquid chromatography/tandem mass spectrometry (LC-MS/MS) J Pharm Biomed Anal 40 2006 382 388 (Pubitemid 43143343)
72. T. He, Q. Zou, Z. Feng, and Z. Zhang Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method Biomed Chromatogr 21 2007 473 479
73. H.C. Bi, Z. Zuo, X. Chen, C.S. Xu, Y.Y. Wen, and H.Y. Sun Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases Xenobiotica 38 2008 185 222
74. M.Z. Xie, and Z.F. Shen Absorption, distribution, excretion and metabolism of cryptotanshinone Yao Xue Xue Bao 18 1983 90 96
75. X.N. Yang, Y.J. Wang, Y.S. Liu, and X. Tang Effects of Panax quinquefolium protopanaxadiol saponins on the animal and human plasma protein binding of salvianolic acids in vitro Asian J Pharm Sci 2 2007 170 179
76. J. Liu, X. Zhao, L. Zhang, M. Fang, W. Sun, and X. Zheng Co-administration of Radix curcumae alters the tissue distribution of danshensu in Radix salviae miltiorrhiae in rabbits Am J Chin Med 36 2008 929 938
77. X. Chen, Z.W. Zhou, C.C. Xue, X.X. Li, and S.F. Zhou Role of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrier Xenobiotica 37 2007 635 678 (Pubitemid 47037157)
78. X.Y. Yu, S.G. Lin, X. Chen, Z.W. Zhou, J. Liang, and W. Duan Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier Curr Drug Metab 8 2007 365 378
79. Z.W. Zhou, X. Chen, J. Liang, X.Y. Yu, J.Y. Wen, and S.F. Zhou Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier Drug Metab Lett 1 2007 205 217
80. Y. Wei, P. Li, C. Wang, Y. Peng, L. Shu, and X. Jia Metabolism of tanshinone IIA, cryptotanshinone and tanshinone I from Radix Salvia miltiorrhiza in zebrafish Molecules 17 2012 8617 8632
81. A. Scalbert, C. Morand, C. Manach, and C. Rémésy Absorption and metabolism of polyphenols in the gut and impact on health Anglais 56 2002 276 282 (Pubitemid 35245310)
82. J. Zhang, Y. He, M. Cui, L. Li, H. Yu, and G.F. Zhang Metabolic studies on the total phenolic acids from the roots of Salvia miltiorrhiza in rats Biomed Chromatogr 19 2005 51 59 (Pubitemid 40305316)
83. R.Z. Wan, Y.Y. Xu, Y. Gu, Y.P. Lin, M.J. Zhou, and C.X. Liu In vivo pharmacokinetics of salvianolic acid B and its metabolite in rats Chin Tradit Chin Med Drugs 42 2011 335 339
84. Y. Cui, M. Xue, Y.J. Luo, and Z.T. Zhou Pharmacokinetics and excretion of cryptotanshinone after intravenous injection in pigs Asian J Drug Metab Pharmacokinet 5 2005 231 235
85. M. Xue, Y. Cui, and H.Q. Wang Pharmacokinetics of cryptotanshinone and its metabolite in pigs Yao Xue Xue Bao 34 1999 81 84
86. Y. Pan, H.C. Bi, and G.P. Zhong Pharmacokinetic characterization of hydroxylpropyl-â-cyclodextrin-included complex of cryptotanshinone, an investigational cardiovascular drug purified from Danshen (Salvia miltiorrhiza) Xenobiotica 38 2008 382 398 (Pubitemid 351380283)
87. X. Li, C. Yu, Y. Lu, Y.L. Gu, J. Lu, and W. Xu Pharmacokinetics, tissue distribution, metabolism, and excretion of depside salts from Salvia miltiorrhiza in rats Drug Metab Dispos 35 2007 234 239 (Pubitemid 46148735)
88. Q. Liu, and R.B. Chao Determination of Danshensu in urine and its pharmacokinetics in human Yao Xue Xue Bao 38 2003 771 774
89. X.N. Yang, Y.J. Wang, Y.S. Liu, and X. Tang Pharmacokinetics of salvianolic acids after intravenous injection, with and without Panax quinquefolium protopanaxadiol saponins, in rats J Ethnopharmacol 117 2008 408 414
90. Y. Chen, I. Jaw, M. Shiao, and T.H. Tsai Determination and pharmacokinetic analysis of salvianolic acid B in rat blood and bile by microdialysis and liquid chromatography J Chromatogr A 1088 2005 140 145 (Pubitemid 41058812)
91. S. Baba, N. Osakabe, and M. Natsume Absorption, metabolism, degradation and urinary excretion of rosmarinic acid after intake of Perilla frutescens extract in humans Eur J Nutr 44 2005 1 9 (Pubitemid 40254228)
92. X. Gong, and N.J. Sucher Stroke therapy in traditional Chinese medicine (TCM): prospects for drug discovery and development Trends Pharmacol Sci 20 1999 191 196
93. W. Li, Y. Tang, Y. Chen, and J.A. Duan Advances in the chemical analysis and biological activities of chuanxiong Molecules 17 2012 10614 10651
94. W.X. Wang, M. Gu, X.G. Jiang, Z.L. Gu, and P.S. Fan Studies on chemical constituents of Ligusticum chuanxiong Chin Tradit Herb Drugs 33 2002 4 5
95. C.Y. Cheng, S.Y. Su, N.Y. Tang, T.Y. Ho, W.Y. Lo, and C.L. Hsieh Ferulic acid provides neuroprotection against oxidative stress-related apoptosis after cerebral ischemia/reperfusion injury by inhibiting ICAM-1 mRNA expression in rats Brain Res 209 2008 136 150 [1]
96. C.Y. Cheng, S.Y. Su, N.Y. Tang, T.Y. Ho, W.Y. Lo, and C.L. Hsieh Ferulic acid inhibits nitric oxide-induced apoptosis by enhancing GABAB1 receptor expression in transient focal cerebral ischemia in rats Acta Pharmacol Sin 31 2010 889 899
97. S.L. Liao, T.K. Kao, W.Y. Chen, Y.S. LiN, S.Y. Chen, and S.L. Raung Tetramethylpyrazine reduces ischemic brain injury in rats Neurosci Lett 372 2004 40 45
98. M.J. Liang, L.C. He, and G.D. Yang Screening, analysis and in vitro vasodilatation of effective components from Ligusticum chuanxiong Life Sci 78 2005 128 133
99. Y. Konishi, Y. Hitomi, M. Yoshida, and E. Yoshioka Intestinal absorption of p-coumaric and gallic acids in rats after oral administration J Agric Food Chem 52 2004 2527 2532
100. A. Adam, V. Crespy, M.A. Levrat-Verny, F. Leenhardt, M. Leuillet, and C. Demigné The bioavailability of ferulic acid is governed primarily by the food matrix rather than its metabolism in intestine and liver in rats J Nutr 132 2002 1962 1968 (Pubitemid 34742885)
101. Q. Cai, Y. Li, and Y.P. Huang In situ absorption of self-microemulsifying soft capsule of volatile oil from rhizome of Ligusticum chuanxiong in rats' intestine Yao Xue Xue Bao 44 2009 425 429
102. X. Qi, C. Ackermann, D. Sun, M. Sheng, and H. Hou Physicochemical characterization and percutaneous delivery of 2,3,5,6-tetramethylpyrazine Int J Pharm 253 2003 177 183 (Pubitemid 36197841)
103. J. Feng, F. Li, Y. Zhao, Y. Feng, and Y. Abe Brain pharmacokinetics of tetramethylpyrazine after intranasal and intravenous administration in awake rats Int J Pharm 375 2009 55 60
104. D. Wu, Y. Zhang, H.M. Yao, and S.M. Li Studies on the intestinal absorption of tetramethylpyrazine phosphate in rats by single pass intestinal perfusion method J Shenyang Pharm Univ 25 2008 695 698
105. Y.Y. Xiao, Z.P. Chen, Q.N. Ping, and H.X. Chen The enhancing effect of borneol on the absorption of tetramethylpyrazine Yao Xue Xue Bao 44 2009 915 921
106. H. Wang, L.L. Gao, W.M. Xu, and G. Liu Transdermal absorption of ligustrazine phosphate in vitro Chin Tradit Chin Med Drugs 31 2000 117 119
107. J.H. Zhao, L. Ji, H. Wang, Z.Q. Chen, Y.T. Zhang, and Y. Liu Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo Int J Nanomedicine 6 2011 1611 1619
108. D. Mei, S. Mao, W. Sun, Y.J. Wang, and T. Kisselb Effect of chitosan structure properties and molecular weight on the intranasal absorption of tetramethylpyrazine phosphate in rats Eur J Pharm Biopharm 70 2008 874 881
109. X. Liu, H. Liu, J. Liu, Z.W. He, C.C. Ding, and G.L. Huang Preparation of a ligustrazine ethosome patch and its evaluation in vitro and in vivo Int J Nanomedicine 6 2011 241 247
110. D. Mei, S.R. Mao, and P.F. Qian Effect of cyclodextrins on the intranasal absorption of tetramethylpyrazine phosphate J Shenyang Pharm Univ 25 2008 933 938
111. D.M. Meng, Y.H. Xu, P.T. Ding, and Y.J. Deng Study on nasal absorption and pharmacokinetics of ligustrazine phosphate Chin Pharm J 44 2009 930 932
112. Y.Y. Xiao, Q.N. Ping, and Z.P. Chen The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse Int J Pharm 337 2007 74 79
113. H.T. Song, T. Guo, Y.X. Zhang, L.P. Kang, T. Xie, and D.W. Chen Intestinal absorption kinetics of ferulic acid in rats in vivo Chin Tradit Chin Med Drugs 36 2005 1514 1517
114. X.G. Yang, D. Li, and H. Guo The absorption kinetics of ferulic acid of Ligusticum chuanxiong extracts in intestines of rat Chin Tradit Chin Med Drugs 38 2007 61 64
115. J.F. Zhang, H.H. Yuan, D. Lin, Q. Tang, and X.Y. Xu Study on pharmacokinetics of ferulic acid loaded liposome in-chitosan-microspheres in rats Zhongguo Zhong yao za zhi 36 2011 1751 1754
116. Y. Li, and K. Bi HPLC determination of ferulic acid in rat plasma after oral administration of Rhizoma Chuanxiong and its compound preparation Biomed Chromatogr 17 2003 543 546 (Pubitemid 38008960)
117. N.L. Ko, C.K. Choo, Y.K. Tam, and G. Lin Study of the oral absorption of the active ingredients of Rhizoma Chuanxiong PharmSci 2003 5
118. Z.L. Huang, C.Q. Gui, and R.Y. Sun Distribution of tetramethylpyrazine hydrochloride in rats Chin Pharmacol Bull 10 1994 297 300
119. L.S. Wang, Q. Guo, J. Han, S. Zhang, H. Wu, and L. Chen Pharmacokinetics of ligustrazine in blood, brain, and liver of mice Chin Tradit Chin Med Drugs 40 2009 935 938
120. L.S. Wang, B.L. Lai, and Z.M. Xia Studies on brain pharmacokinetics of xiongbing microemulsion by microdialysis technique in awake and freely-moving rats Tradit Chin Drug Res Clin Pharmacol 22 2011 299 303
121. F.Z. Li, Y.R. Feng, and J. Feng Studies on brain pharmacokinetics of tetramethylpyrazine hydrochloride after intranasal administration in rats Chin Pharm J 43 2008 452 454
122. W. Ho, H. Wen, and C. Lee Tetramethylpyrazine for treatment of experimentally induced stroke in Mongolian gerbils Stroke 20 1989 96 99 (Pubitemid 19040220)
123. T.H. Tsai, and C.C. Liang Pharmacokinetics of tetramethylpyrazine in rat blood and brain using microdialysis Int J Pharm 216 2001 61 66
124. J.W. Ni, K. Matsumoto, and H. Watanabe Tetramethylpyrazine improves spatial cognitive impairment induced by permanent occlusion of bilateral common carotid arteries or scopolamine in rats Jpn J Pharmacol 67 1995 137 141
125. J. Qin, D.W. Chen, W.G. Lu, H. Xu, C.Y. Yan, and H.Y. Hu Preparation, characterization, and evaluation of liposomal ferulic acid in vitro and in vivo Drug Dev Ind Pharm 34 2008 602 608 (Pubitemid 351878677)
126. Y. Shi, L. He, and S. Wang Determination of ligustilide in rat blood and tissues by capillary gas chromatography/mass spectrometry Biomed Chromatogr 20 2006 993 998 (Pubitemid 44697034)
127. J. Guo, J.A. Duan, E.X. Shang, Y.P. Tang, and D.W. Qian Determination of ligustilide in rat brain after nasal administration of essential oil from Rhizoma Chuanxiong Fitoterapia 80 2009 168 172
128. J.M. Guo, E.X. Shang, J.A. Duan, Y.P. Tang, and D.W. Qian Determination of ligustilide in the brains of freely moving rats using microdialysis coupled with ultra performance liquid chromatography/mass spectrometry Fitoterapia 82 2011 441 445
129. X. Chen, and S.N. Dong Studies on the metabolites of tetramethylpyrazine in rabbits Yao Xue Xue Bao 31 1996 5
130. J. Jiang, G.H. Jiang, Y.P. Ye, and S.Z. Wang The metabolism of TMPz in vivo Zhongguo Yi Xue Ke Xue Yuan Xue Bao 15 1993 9 82
131. X.D. Kuang, X.H. Li, and Y.Q. Xiong Study on metabolism of tetramethylpyrazine in system of rat liver microsomes Zhongguo Zhong yao za zhi 31 2006 1971 1975
132. L. Rondini, M.N. Peyrat-Maillard, A. Marsset-Baglieri, and C.B. Ensia Sulfated ferulic acid is the main in vivo metabolite found after short-term ingestion of free ferulic acid in rats J Agric Food Chem 50 2002 3037 3041 (Pubitemid 34493622)
133. J.L. Zhang, G.D. Zhang, and T.H. Zhou Metabolism of ferulic acid in rats J Asian Nat Prod Res 7 2005 5 49
134. Z.C. Zhang, M. Xu, S.F. Sun, X. Qiao, B.R. Wang, J. Han, and D.A. Guo Metabolic analysis of four phenolic acids in rat by liquid chromatography-tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci 871 2008 7 14
135. R. Yan, N.L. Ko, S.L. Li, Y.K. Tam, and G. Lin Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat Drug Metab Dispos 36 2008 400 408 (Pubitemid 351185754)
136. C.G. Ding, Y.X. Sheng, Y.H. Zhang, J.L. Zhang, and G.H. Du Identification and comparison of metabolites after oral administration of essential oil of Ligusticum chuanxiong or its major constituent ligustilide in rats Planta Med 74 2008 1684 1692
137. M. Qian, L.F. Shi, and J.H. Hu Enzyme kinetics of ligustilide metabolism in rat liver microsomes Yao Xue Xue Bao 44 2009 395 400
138. R. Yan, N.L. Ko, S.L. Li, Y.K. Tam, and G. Lin Metabolic conversion from co-existing ingredient leading to significant systemic exposure of Z-butylidenephthalide, a minor ingredient in Chuanxiong Rhizoma in rats Curr Drug Metab 13 2012 524 534
139. Y.Q. Lou, H. Zhang, X. Cao, and M.L. Chen The pharmacokinetics and disposition of tetramethylpyrazine phosphate in dogs and rats Yao Xue Xue Bao 21 1986 481 487
140. L.C. Bourne, and C. Rice-Evans Bioavailability of ferulic acid Biochem Biophys Res Commun 253 1998 222 227 (Pubitemid 29026685)
141. Z. Zhao, Y. Egashira, and H. Sanada Ferulic acid sugar esters are recovered in rat plasma and urine mainly as the sulfoglucuronide of ferulic scid J Nutr 133 2003 1355 1361 (Pubitemid 36548706)
142. J. Westendorf, and G. Czok Biliary excretion of choleretically active cinnamic acid derivatives in the rat Z Ernahrungswiss 22 1983 6
143. Y.S. Hwang, C.Y. Shin, Y. Huh, and J.H. Ryu Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats Life Sci 71 2002 2105 2117
144. H.J. Koo, S. Lee, and K.H. Shin Geniposide, an anti-angiogenic compound from the fruits of Gardenia jasminoides Planta Med 70 2004 467 469 (Pubitemid 38716483)
145. Y. Suzuki, K. Kondo, Y. Ikeda, and K. Umemura Antithrombotic effect of geniposide and genipin in the mouse thrombosis model Planta Med 67 2001 807 810 (Pubitemid 34015542)
146. F. Yoshino, A. Yoshida, N. Umidai, K. Kubo, and M.C. Lee Crocetin reduces the oxidative stress induced reactive oxygen species in the stroke-prone spontaneously hypertensive rats (SHRSPs) brain J Clin Biochem Nutr 49 2011 182 187
147. Z.J. Zhang, P. Li, Z. Wang, P.T. Li, W.S. Zhang, and Z.H. Sun A comparative study on the individual and combined effects of baicalin and jasminoidin on focal cerebral ischemia-reperfusion injury Brain Res 1123 2006 188 195 (Pubitemid 44794386)
148. X.L. Zhu, N. Zhang, P.T. Li, Y.F. Jiang, and Y. Xu Protective effect of jasminoidin on cascade of damage of cerebral ischemia in rats Zhongguo Zhong yao za zhi 29 2004 43 46
149. M.C. Bergonzi, C. Righeschi, B. Isacchi, and A.R. Bilia Identification and quantification of constituents of Gardenia jasminoides Ellis (Zhizi) by HPLC-DAD-ESI-MS Food Chem 2 2012 1199 1204
150. S.C. Wang, T.Y. Tseng, C.M. Huang, and T.H. Tsai Gardenia Chinese medicine active constituents: applicable separation procedures J Chromatogr B Analyt Technol Biomed Life Sci 812 2004 193 202
151. Z.M. Long, R.W. Zhang, X. Zhao, X. Meng, K. Bi, and X.H. Chen Determination and pharmacokinetics of geniposidic acid in rat plasma after oral administration of Gardenia jasminoides fruit crude extract and Zhi-zi-chi decoction Biomed Chromatogr 2013 10.1002/bmc.2871
152. S.Y. Du, Q.Y. Zhang, Y. Lu, Y.S. Zhai, and Q. Wu Study of components in Xingnaojing affecting intestine absorption of Gardenia extract Zhongguo Zhong yao za zhi 35 2010 297 300
153. X.H. Du, X. Niu, Q.J. Feng, H. Du, and H.Y. Li Study on absorption kinetics of geniposide in rat intestines W China J Pharm Sci 23 2008 558 560
154. Q.Y. Zhang, S.Y. Du, Y. Lu, and X.L. Rao Studies on O/W partition coefficient and absorption kinetics of geniposide in fructus Gardeniae extract in rat intestine Zhongguo Zhong yao za zhi 34 2009 1840 1844
155. Y.Q. Hu, L.Y. Zheng, C.Q. Qian, and W.H. Yu Absorption of phenol red from rat intestine J Chin Pharm Univ 27 1996 355 359
156. Y. Lu, X. Chen, S. Du, Q. Wu, Z. Yao, and Y. Zhai The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats Arch Pharm Res 33 2010 691 696
157. Y. Sun, F. Feng, and X. Yu Pharmacokinetics of geniposide in Zhi-Zi-Hou-Pu decoction and in different combinations of its constituent herbs Phytother Res 26 2012 67 72
158. S. Chula, L. Hang, B. Yinying, S. Jianning, and R. Shi The effects of notoginsenoside R1 on the intestinal absorption of geniposide by the everted rat gut sac model J Ethnopharmacol 1 2012 136 143
159. Y. Lu, S. Du, J. Bai, P.Y Li, R. Wen, and X.J. Zhao Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice Int J Mol Sci 11 2012 14127 14135
160. M. Yang, X.Y. Chen, H.Y. Zhang, J.M. Wang, Q. Lu, and W. Song Pharmacokinetics of geniposide through 4 routes of administration Chin New Drug J 19 2010 749 754
161. M.F. Zeng, H.X. Zhu, L.M. Pan, Q.C. Zhang, and L.W. Guo Studies on pharmacokinetics of geniposide in normal and cerebral ischemia rats Chin Tradit Chin Med Drugs 41 2010 617 620
162. H.Y. Jin The study on Phamraeokinetics of Shuluo effctvie compounds 2005
163. T. Tseng, and T. Tsai Measurement of unbound geniposide in blood, liver, brain and bile of anesthetized rats: an application of pharmacokinetic study and its influence on acupuncture Anal Chim Acta 517 2004 47 52 (Pubitemid 38798306)
164. B. Yu, M. Ruan, X.B. Cui, J.M. Guo, L. Xu, and X.P. Dong Effects of borneol on the pharmacokinetics of geniposide in cortex, hippocampus, hypothalamus and striatum ofconscious rat by simultaneous brain microdialysis coupled with UPLC-MS J Pharm Biomed Anal 77 C Jan 29 2013 128 132 10.1016/j.jpba.2013.01.017
165. T. Akao, K. Kobashi, and M. Aburada Enzymic studies on the animal and intestinal bacterial metabolism of geniposide Biol Pharm Bull 17 1994 1573 1576
166. Y. Kawata, M. Hattori, T. Akao, K. Kobashi, and T. Namba Formation of nitrogen-containing metabolites from geniposide and gardenoside by human intestinal bacteria Planta Med 57 1991 536 542
167. M. Miyagoshi, S. Amagaya, and Y. Ogihara Structural transformation of geniposide, gardenoside, and related compounds in rat gastrointestinal contents Planta Med 54 1988 556 557 (Pubitemid 19007998)
168. J.S. Yim, Y.S. Kim, S.K. Moon, K.H. Cho, H.S. Bae, and J.J. Kim Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora Biol Pharm Bull 27 2004 1580 1583
169. Y.C. Hou, S.Y. Tsai, P.Y. Lai, Y.S. Chen, and P.D. Chao Metabolism and pharmacokinetics of genipin and geniposide in rats Food Chem Toxicol 46 2008 2764 2769
170. H. Han, L. Yang, Y. Xu, Y. Ding, S.W.A. Bligh, and T. Zhang Identification of metabolites of geniposide in rat urine using ultra-performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight tandem mass spectrometry Rapid Commun Mass Spectrom 25 2011 3339 3350
171. L.R. Zhang Study on pharmacokinetic of geniposide compared with gardeniae and its compound of traditional Chinese medicine in rat 2004 ShenYang Pharmaceutical University Shenyang
172. X.Z. Li, S.N. Zhang, S.M. Liu, and F. Lu Recent advances in herbal medicines treating Parkinson's disease Fitoterapia 84 2013 273 285
173. J.X. Song, S.C. Sze, T.B. Ng, C.K. Lee, G.P. Leung, and P.C. Shaw Anti-Parkinsonian drug discovery from herbal medicines: what have we got from neurotoxic models? J Ethnopharmacol 139 2012 698 711
174. L. Cheng, H.J. Yang, R.X. Liang, L. Huang, and G.Z. Zong Pharmacokinetics of geniposide and its metabolite in rats I Zhongguo Zhong yao za zhi 32 2007 61 63